About Roxas Pharmaceuticals Private Limited
Data last updated:
Roxas Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2014PTC267018. Its GSTIN is 07AAGCR8760H1Z0 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shivani and Pradeepkumar Virendrasingh Phougat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 14 G/F Pkt E Mayur Vihar Ph – II, Delhi, India – 110091.
As per the financials filed for FY 2024, the company reported a revenue of ₹33.66 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net loss of ₹9.74 Lakh (net margin -28.9%) and EBITDA of -₹8.62 Lakh (EBITDA margin -25.6%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 11% over five years.
The company is associated with 1 brand: Roxas Pharmaceuticals. As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website roxaspharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShop No. 14 G/F Pkt E Mayur Vihar Ph – II, Delhi, India – 110091
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Roxas Pharmaceuticals Private Limited
The main business activity of Roxas Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Roxas Pharmaceuticals Private Limited FY 2025 filings available
Roxas Pharmaceuticals Private Limited reported revenue of ₹33.66 Lakh (up 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Roxas Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 6% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Roxas Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹8.62 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹9.74 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Roxas Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -25.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -28.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Roxas Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Roxas Pharmaceuticals Private Limited
Roxas Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aarati Pharmaceuticals Private Limited | ₹33.93 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Adhisvar Pharmaceuticals Private Limited | ₹33.85 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Vadodara, Gujarat, India |
| Elite Medicare Private Limited | ₹33.82 Lakh (FY 2025) | •••• | •••• | 12.0% | •••• | Ahmedabad, Gujarat, India |
| Nyla Pharmaceuticals Private Limited | ₹33.78 Lakh (FY 2024) | •••• | •••• | -24.0% | •••• | Aurangabad, Maharashtra, India |
| LN Pharmaceuticals Private Limited | ₹33.71 Lakh (FY 2025) | •••• | •••• | 447.0% | •••• | Hyderabad, Telangana, India |
| Roxas Pharmaceuticals Private Limited this company | ₹33.66 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Delhi, India |
| Medikay Pharma Private Limited | ₹33.64 Lakh (FY 2025) | •••• | •••• | -5.0% | •••• | New Delhi, Delhi, India |
| Sunflex Remedies Private Limited | ₹33.59 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | New Delhi, Delhi, India |
| Fablums Medicare Private Limited | ₹33.54 Lakh (FY 2020) | •••• | •••• | -57.0% | •••• | Thrissur, Kerala, India |
| JVD Pharma Private Limited | ₹33.53 Lakh (FY 2024) | •••• | •••• | 14.0% | •••• | New Delhi, Delhi, India |
| Capwell Pharmaceuticals Private Limited | ₹33.52 Lakh (FY 2024) | •••• | •••• | -2.0% | •••• | Faizabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Roxas Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Roxas Pharmaceuticals Private Limited
Roxas Pharmaceuticals Private Limited is audited by J P R M S & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J P R M S & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Roxas Pharmaceuticals Private Limited
Roxas Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivani | Director | 21 Aug 2017 | 9 Years 1 Months | Current |
| Pradeepkumar Virendrasingh Phougat | Director | 26 Mar 2014 | 12 Years 6 Months | Current |
Ownership and Shareholding of Roxas Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Roxas Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Sep 2015 | State Bank of Patiala | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Associated Brands with Roxas Pharmaceuticals Private Limited
Roxas Pharmaceuticals operates one associated brand: Roxas Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and marketing of branded and generic pharmaceutical formulations in India. | roxaspharmaceuticals.com |
Employees and EPFO Compliance at Roxas Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Roxas Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Roxas Pharmaceuticals Private Limited
Roxas Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Harender Singh ceased to be Director on 21 Aug 2017.
Credit Ratings, Litigation & Regulatory Alerts for Roxas Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Roxas Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Roxas Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Roxas Pharmaceuticals Private Limited
Roxas Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCR8760H1Z0 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Roxas Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Roxas Pharmaceuticals Private Limited
Roxas Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 March 2014 (12+ years old) and is registered under CIN U74900DL2014PTC267018.
Roxas Pharmaceuticals reported revenue of ₹33.66 Lakh for FY 2024 (up 6% YoY).
Roxas Pharmaceuticals has 2 current directors:
- Shivani - Director
- Pradeepkumar Virendrasingh Phougat - Director
Roxas Pharmaceuticals reported a net loss of ₹9.74 Lakh (net margin -28.9%) and EBITDA of -₹8.62 Lakh (EBITDA margin -25.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Roxas Pharmaceuticals is 9% over three years and 11% over five years. In the latest year (FY 2024) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Roxas Pharmaceuticals is 07AAGCR8760H1Z0, registered in Delhi.
The CIN (Corporate Identification Number) of Roxas Pharmaceuticals is U74900DL2014PTC267018. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Roxas Pharmaceuticals was incorporated on 26 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Roxas Pharmaceuticals by revenue are Aarati Pharmaceuticals Private Limited, Adhisvar Pharmaceuticals Private Limited, Elite Medicare Private Limited, Nyla Pharmaceuticals Private Limited, LN Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Harender Singh ceased to be Director on 21 Aug 2017. Shivani was appointed as Director on 21 Aug 2017. Pradeepkumar Virendrasingh Phougat was appointed as Director on 26 Mar 2014.
Roxas Pharmaceuticals can be reached through the website roxaspharmaceuticals.com. Its registered office is in Delhi, India.